Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
ID06080464

A Study of Clinician Satisfaction and Likelihood of Clinical Adoption of the VERABAND174; Wearable Activity Monitor for Chronic Low Back Pain

Led by University of Michigan · Updated on 2026-06-03

360

Participants Needed

3

Research Sites

26 weeks

Total Duration

On this page

Sponsors

U

University of Michigan

Lead Sponsor

N

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating clinician satisfaction and the likelihood of clinical adoption of the VERABAND174; a newly developed, disposable, wearable activity monitor designed for people with chronic low back pain (cLBP). This study involves multiple clinical sites and aims to assess how useful and user-friendly the VERABAND system is for managing cLBP, regardless of the specific pain treatments used. The study is conducted under an approved institutional review board protocol with an estimated 340 patient participants and 20 clinicians across tertiary pain clinics. Participants diagnosed with cLBP who are ambulatory and beginning a new non-surgical pain treatment will receive a VERABAND activity monitor during their initial clinic visit. The monitor continuously tracks activity until the patient's next clinic visit, and weekly summary reports from the device will be provided to their treating clinicians before follow-up visits. Clinicians will complete a survey measuring their satisfaction with the VERABAND's usability and its potential usefulness for different patient profiles at the end of each patient's care episode. During the study, patient participants are monitored longitudinally through their normal care visits while wearing the VERABAND device. Researchers will collect clinician feedback using the System Usability Scale over approximately seven weeks to measure satisfaction and adoption likelihood. The study focuses on how well the device supports clinical management of cLBP and explores whether it is more helpful for patients with varying pain levels or psychological characteristics. The total study duration extends up to the follow-up visit after starting new treatments.

CONDITIONS

Brief Title

Clinician Satisfaction With the VERABAND™

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ambulatory
  • Diagnosis of chronic low back pain according to NIH Task Force criteria
  • Low back pain that interferes with mobility
  • Starting a new non-surgical treatment or combination of treatments for chronic low back pain
  • Willing to wear the VERABAND174; continuously until next clinic visit and return used devices by mail
  • Age between 18 and 85 years
Not Eligible

You will not qualify if you...

  • Signs of ongoing systemic disease such as fever, weight loss, pain after major trauma, immunosuppression, recent infection, or severe sensory/motor problems
  • Inability to speak and write English
  • Visual or hearing difficulties that prevent participation
  • Severe psychiatric disorders, including active suicidal thoughts or history of suicide attempts
  • Receiving disability or compensation or involved in litigation
  • Scheduled surgery before follow-up visit

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Approximately 7 weeks

Participants receive a VERABAND™ activity monitor during an initial clinic visit and begin a new pain treatment regimen as part of their normal ongoing care while wearing the device continuously.

Baseline visit and follow-up clinic visits

Follow-up

Duration - Approximately 7 weeks

Participants continue to be tracked longitudinally while clinicians receive weekly activity data reports from the VERABAND™ device prior to each follow-up clinic visit to support clinical management.

Weekly visits for up to 7 weeks

Trial Site Locations

Total: 3 locations

1

Altman Clinical and Translational Research Institute

La Jolla, California, United States, 92037

Not Yet Recruiting

2

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160

Actively Recruiting

3

University of Michigan

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

Loading map...

Research Team

K

Kristi Pickup, MSW

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

1

Similar Trials

Lumbar Operatively Inserted PerQdisc Artificial Implant Foll...

Degenerative Disc Disease

Actively Recruiting

10 locations

A Master Protocol for Randomized, Placebo-Controlled Phase 2...

Osteoarthritis, Knee

Actively Recruiting

64 locations

Alberta Chiropractic SelfBack Study to Evaluate the Feasibil...

Chronic Low-back Pain

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here